Carol Nairn carol.nairn@crbusa.com & & +1 816-880-9800

Carol Nairn

Process Engineer at CRB

Switzerland

*50 free lookup(s) per month.

No credit card required.

Carol Nairn’s Emails [email protected]

Carol Nairn’s Phone Numbers +1816880****

Social Media

Carol Nairn’s Location Switzerland

Carol Nairn’s Expertise Process Engineer at CRB

Carol Nairn’s Current Industry CRB

Not the Carol Nairn you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

CRB

Process Engineer

2023-03-01 — Present

GSK

Engineering Project Manager

2022-04-01 — 2023-02-01

GSK

Biopharmaceutical Associate

2018-01-01 — 2022-04-01

GSK

Biopharmaceutical Associate

2016-09-01 — 2018-01-01

KCP Environmental Services Ltd.

Graduate Research Associate

2016-05-01 — 2016-08-01

Universidad Rey Juan Carlos

Masters Student

2016-01-01 — 2016-04-01

University of Strathclyde

Class Tutor - Basic Principles in Chemical Engineering

2014-10-01 — 2015-12-01

Novartis

Technical Research & Development Intern

2014-06-01 — 2014-08-01

GSK

Process Engineering Summer Intern

2013-06-01 — 2013-08-01

Frank Morton Strathclyde 2014

Sponsorship and Liaison Coordinator

2013-05-01 — 2013-10-01

University of Strathclyde

Residence Assistant

2012-09-01 — 2013-01-01

Skills

engineering architecture construction consulting biotechnology food beverage life sciences pharmaceuticals science

Languages

FAQ About Carol Nairn

Carol Nairn is located at
Switzerland

Carol Nairn is a
Process Engineer at CRB CRB

Carol Nairn currently works in the
CRB

Carol Nairn specializes in
Process Engineer at CRB

Carol Nairn speaks the following languages:
English

Carol Nairn has prior experience in the following industries:
GSK , GSK , GSK , KCP Environmental Services Ltd. , Universidad Rey Juan Carlos , University of Strathclyde , Novartis , GSK , Frank Morton Strathclyde 2014 , University of Strathclyde

Carol Nairn has the following professional experience:
CRB , GSK , GSK , GSK , KCP Environmental Services Ltd. , Universidad Rey Juan Carlos , University of Strathclyde , Novartis , GSK , Frank Morton Strathclyde 2014 , University of Strathclyde .